Skip to main content
Jacqueline French, MD, Neurology, New York, NY, NYU Langone Hospitals

JacquelineFrenchMD

Neurology New York, NY

Epilepsy

Professor of Neurology, NYU School of Medicine

Dr. French is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. French's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 1982 - 1988
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1984 - 2025
  • PA State Medical License
    PA State Medical License 1989 - 2014
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2009-2014
  • New York Magazine: Top Doctors Castle Connolly, 2008-2014
  • America's Top Doctors Castle Connolly, 2002-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Changes in Seizure Frequency and Antiepileptic Therapy During Pregnancy  
    Page B Pennell, Jacqueline A French, Laura Kalayjian, Patricia Penovich, Evan Gedzelman, Alison M Pack, Kimford J Meador, The New England Journal of Medicine

Press Mentions

  • Xenon Pharmaceuticals Showcases Its XEN1101 Epilepsy Program at the 2023 American Academy of Neurology (AAN) Annual Meeting
    Xenon Pharmaceuticals Showcases Its XEN1101 Epilepsy Program at the 2023 American Academy of Neurology (AAN) Annual MeetingApril 24th, 2023
  • How Epilepsy Researchers Are Moving the Needle Past Anti-Seizure Treatments
    How Epilepsy Researchers Are Moving the Needle Past Anti-Seizure TreatmentsFebruary 13th, 2023
  • Engrail Therapeutics Announces Positive Results of ENX-101 Phase 1b Clinical Study and Prepares for Initiation of ENACT Phase 2 Trial in Focal Epilepsy
    Engrail Therapeutics Announces Positive Results of ENX-101 Phase 1b Clinical Study and Prepares for Initiation of ENACT Phase 2 Trial in Focal EpilepsyJune 7th, 2022
  • Join now to see all

Committees

  • AAN Guideline Historian, Ex-Officio, Voting, Guideline Development Subcommittee of the American Academy of Neurology 2016 - Present
  • Author, Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society 2015 - Present

Professional Memberships

Hospital Affiliations